Agile Therapeutics Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
A very red day for Agile Therapeutics stock price after a -6.09% fall in the Tuesday trading session
(Updated on Apr 23, 2024)
The Agile Therapeutics stock price fell by -6.09% on the last day (Tuesday, 23rd Apr 2024) from $0.394 to $0.370. During the last trading day the stock fluctuated 9.74% from a day low at $0.365 to a day high of $0.400. The price has risen in 6 of the last 10 days and is up by 0.33% over the past 2 weeks. Volume has increased on the last day by 79 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 95 thousand shares were bought and sold for approximately $34.98 thousand.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.372 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
AGRX Signals & Forecast
A buy signal was issued from a pivot bottom point on Monday, April 01, 2024, and so far it has risen 37.04%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Agile Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.377 and $0.480. A break-up above any of these levels will issue buy signals. Agile Therapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Agile Therapeutics stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.340 and $0.334. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Agile Therapeutics finds support just below today's level at $0.340. If this is broken, then the next support from accumulated volume will be at $0.334 and $0.290.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0355 between high and low, or 9.74%. For the last week, the stock has had daily average volatility of 9.14%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (AGRX) For The Upcoming Trading Day Of Wednesday 24th
For the upcoming trading day on Wednesday, 24th we expect Agile Therapeutics to open at $0.378, and during the day (based on 14 day Average True Range), to move between $0.306 and $0.434, which gives a possible trading interval of +/-$0.0639 (+/-17.27%) up or down from last closing price. If Agile Therapeutics takes out the full calculated possible swing range there will be an estimated 34.54% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.386 (4.21%) than the support at $0.340 (8.11%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Agile Therapeutics stock A Buy?
Agile Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Current score: -5.999 Strong Sell Candidate Downgraded
Predicted Opening Price for Agile Therapeutics of Wednesday, April 24, 2024
| Fair opening price April 24, 2024 | Current price |
|---|---|
| $0.378 ( 2.21%) | $0.370 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for AGRX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.414 | 11.80 % | |
| R2 | 0.400 | 8.14 % | ||
| R1 | 0.392 | 5.87 % | ||
| Current price: | 0.370 | |||
| Support | S1 | 0.365 | -1.46 % | |
| S2 | 0.356 | -3.72 % | ||
| S3 | 0.343 | -7.39 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.420 | 13.56 % | |
| R2 | 0.394 | 6.49 % | ||
| R1 | 0.386 | 4.21 % | ||
| Current price | 0.370 | |||
| Support | S1 | 0.340 | -8.11% | |
| S2 | 0.334 | -9.73% | ||
| S3 | 0.290 | -21.62% |
FAQ
Click here for our free guide on how to buy Agile Therapeutics Stock.
